D29.1 — Benign neoplasm of prostate
Is D29.1 billable?
Yes — D29.1 is billable for FY2027. D29.1 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. D29.1 may be submitted for encounters from October 1, 2026 through September 30, 2027.
D29.1 at a glance
| Code | D29.1 |
|---|---|
| Description | Benign neoplasm of prostate |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does D29.1 group to?
D29.1 sits in MDC 12 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 729Other Male Reproductive System Diagnoses with CC/MCCmedical
- 730Other Male Reproductive System Diagnoses without CC/MCCmedical
How is D29.1 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to D29.1. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Fibroadenoma › prostate
- Myoma › prostate
Excludes1 — never code together
The conditions below can never be reported together with D29.1 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- enlarged prostate (N40.-)
How long has D29.1 existed?
D29.1 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.
Which codes are confused with D29.1?
ICD-10-CM declares these codes mutually exclusive with D29.1 — exactly one of each pair can be correct for a given encounter.